Tuesday, May 13, 2025
HomeTagsOncology

Oncology

AbbVie and Neomorph Collaborate on Molecular Glue Degraders

AbbVie and Neomorph, announced a collaboration and option-to-license agreement to develop novel molecular glue degraders for multiple targets across oncology and immunology. Molecular glue degraders...

Innovent Launches Environmental, Social and Governance (ESG) Website to Advance Sustainability and Corporate Responsibility

Environmental, Social and Governance (ESG) criteria are key indicators of a company's long-term sustainability. Innovent Biologics has been actively addressing the United Nations' Sustainable...

Calibre Scientific Acquires DCS, a German Provider of Antibodies, Reagents and Equipment Used in Immunohistochemistry

Calibre Scientific is pleased to announce the acquisition of DCS Innovative Diagnostik-Systeme GmbH & Co. KG, a German supplier of reagents and equipment used...

Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC

Tempus, a leader in artificial intelligence and precision medicine, announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm physicians with...

Ryght Welcomes Dr. Chadi Nabhan as Chief Medical Officer and Head of Strategy

Ryght, a leading healthcare technology company, announced the appointment of physician and author, Chadi Nabhan, MD, MBA, as its new Chief Medical Officer and...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics